Estudio del protooncogen RET en neoplasia endocrina multiple 2A y en carcinoma medular de tiroides familiar. Hallazgos clínico-patológicos en portadores asintomáticos.

Belli, Susana; Storani, María E; Dourisboure, Ricardo J; Podestá, Ernesto J; Solano, Angela R.
Medicina [B Aires] ; 63(1): 41-5, 2003.
Artículo en Español | BINACIS | ID: bin-39013

Documentos relacionados

  1. [Study of RET protooncogene in multiple endocrine neoplasm 2A and in familial medullary thyroid carcinoma. Clinical pathological findings in asymptomatic carriers].
  2. Estudio del protooncogen RET en neoplasia endocrina multiple 2A y en carcinoma medular de tiroides familiar. Hallazgos clinico-patologicos en portadores asintomaticos
  3. Estudio del protooncogen RET en neoplasia endocrina multiple 2A y en carcinoma medular de tiroides familiar. Hallazgos clinico-patologicos en portadores asintomaticos
  4. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
  5. Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience.
  6. [Prophylactic thyroidectomy in RET proto-oncogen mutation].
  7. False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A.
  8. Cardio<b>-</b>facio<b>-</b>cutaneous syndrome with BRAF gene mutation: A case report and literature review.
  9. INCREASED SERUM CALCITONIN IN SPORADIC PRIMARY HYPERPARATHYROIDISM IS AN UNCOMMON OCCURRENCE.
  10. Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.